EPAM · EPAM Systems

The thesis

EPAM Systems is shrinking its share count quickly while organic growth stays close to flat, and the shares are modestly more likely than not to beat the S&P 500 over the next three months. The February 2027 outlook settles it. It shows whether three large deals signed in the third quarter lift growth above the 0.5%–1.6% organic constant-currency rate guided for the fourth quarter.

The capital-return half of the case is in a filing. EPAM's 8-K dated 10 November 2026 says the company signed a $500 million accelerated share repurchase with UBS on 9 November 2026. Under it, EPAM expected to receive 2,550,695 shares up front by 10 November 2026, worth $400 million at the 9 November 2026 close. The rest settles in the first quarter of 2027. Cash on hand and borrowings under the existing credit facility pay for it.

The shares closed at $163.83 on 12 November 2026, up 63.0% over three months (adjusted daily closes). The price already reflects the third-quarter beat and the buyback: the 12 November 2026 close sits $1.87 below the $165.70 close on 5 November 2026, the report day. The rating is Medium because the buyback is now contracted and funded, while the growth recovery stays untested until the February 2027 report.

Bullish and bearish views on EPAM SYSTEMS, INC.

The bull case on EPAM SYSTEMS, INC. (EPAM), in brief: the repurchase was signed on schedule. The bear case: growth is guided to slow again.

Bull case

• The repurchase was signed on schedule. The UBS agreement was dated 9 November 2026, with 2,550,695 shares due up front (8-K, 10 November 2026). It sits under the $1.8 billion authorization approved on 30 September 2026.
• Results beat and earnings guidance rose. Third-quarter revenue was $1.426 billion, above the $1.410 billion–$1.425 billion guidance. Fiscal 2026 adjusted earnings per share (EPS) guidance rose to $13.23–$13.31 from $13.08–$13.24 (8-K, 5 November 2026).
• Capital return is a multi-year commitment. EPAM committed to return at least 50% of free cash flow each year from 2027 to 2029 and guides fourth-quarter diluted shares to 49.9 million, against 52.0 million for fiscal 2026 (8-K, 5 November 2026).
• The balance sheet can carry the buyback. Cash and equivalents were $965.2 million and long-term debt was $25.0 million at 30 September 2026 (8-K, 5 November 2026).
• AI-native revenue is growing quickly. Management reported more than $185 million in the third quarter, about 13% of revenue, and raised the 2026 target to at least $650 million from $600 million (5 November 2026 call, Motley Fool transcript).
• Analyst targets kept rising after the report. Citigroup raised its target to $172 with a Neutral rating on 11 November 2026 (Benzinga). Needham's target is $200 (Buy, 5 November 2026); Guggenheim's and Susquehanna's are $190 (6 November 2026).

Bear case

• Growth is guided to slow again. Organic constant-currency growth went from 3.4% in the second quarter to 2.5% in the third, and fourth-quarter guidance is 0.5%–1.6% (8-Ks, 6 August 2026 and 5 November 2026). Management said on the 5 November 2026 call that double-digit growth is "definitely not" in 2027.
• Fourth-quarter revenue guidance missed expectations. The $1.405 billion–$1.420 billion guide was 0.6% below the analyst consensus at the midpoint, according to StockStory's 5 November 2026 earnings report.
• Older work is shrinking. Management said on the 5 November 2026 call that some non-AI services declined as clients shifted spending toward AI work.
• The price sits above two neutral targets. The $163.83 close on 12 November 2026 is above Truist's $150 Hold target and Wedbush's $160 Neutral target, both set on 6 November 2026 (Benzinga), and $8.17 under Citigroup's $172 Neutral target.
• Debt now funds part of the buyback. The UBS repurchase is paid partly from credit facility borrowings (8-K, 10 November 2026), and a mixed securities shelf with undisclosed terms was filed on 5 November 2026 (Benzinga).
• An executive sold into the rally. Chief People Officer Lawrence Solomon exercised 3,299 options at $112.62 and sold 3,299 shares at $160.14 on 12 November 2026 (SEC Form 4).

Price setup

The shares closed at $165.70 on 5 November 2026, the report day, then $159.31 on 6 November 2026, $156.82 on 9 November 2026, $164.14 on 10 November 2026, $162.82 on 11 November 2026 and $163.83 on 12 November 2026. The post-report range has held between $156.82 and $165.70 for six sessions.

The last close stands well above the 50-day moving average of $125.48 and the 200-day moving average of $119.20 as of 12 November 2026 (adjusted daily closes). The 3-month gain of 63.0% runs from the $100.50 close on 14 August 2026. The 52-week closing low was $76.04 on 22 June 2026. The 12 November 2026 close is 26.4% below the 52-week intraday high of $222.53, set on 15 January 2026, so the rally has recovered only part of the decline from January.

Catalysts ahead

• ~February 2027 (est.): Q4 2026 results and detailed 2027 guidance; no date has been set. Shows whether the three large deals signed in the third quarter lift organic growth above the 0.5%-1.6% guided for the fourth quarter, and whether 2027 margin lands within 15%-16%.
• ~2027-Q1 (est.): Final settlement of the $500 million UBS accelerated share repurchase. Sets the final number of shares retired beyond the 2,550,695 delivered up front, which feeds the 2027 diluted share count.

What would change the view

A weekly close below $134.70, the 29 October 2026 close, which would undo the gain from the third-quarter report. Fourth-quarter revenue below $1.405 billion, or a 2027 outlook with organic constant-currency growth no better than 0.5%–1.6%, would also end the case.

The risks this note tracks, each with what would confirm it:

• The growth recovery does not arrive and revenue stays flat as older services decline faster than AI-native work grows. Confirmed by: Q4 revenue below $1.405B, or a February 2027 outlook with organic constant-currency growth no better than the fourth quarter's 0.5%-1.6%.
• The shares have run ahead of neutral analysts after a 63.0% three-month rise. Confirmed by: further target changes clustering near Truist's $150, Wedbush's $160 and Citigroup's $172, or downgrades from the Buy-rated firms.
• Margin pressure in 2027 offsets the EPS benefit of a lower share count. Confirmed by: February 2027 guidance for adjusted operating margin at or below the 15% low end of management's preliminary range.
• Debt-funded buybacks and the mixed shelf lead to an issuance that works against the repurchase. Confirmed by: a prospectus supplement or 8-K announcing a share or debt sale with disclosed terms.
• Insiders sell into the post-report rally in size. Confirmed by: further Form 4 open-market sales by the CEO, CFO or directors beyond option-linked sales.
• Engine Capital escalates because the board did not address its strategic-review demand. Confirmed by: a new public letter from Engine, a larger disclosed stake or a director nomination.

What it trades with

EPAM closed higher on 5 November 2026, the day Benzinga reported the Nasdaq down more than 3% in an AI-led sell-off, so the report-day move was specific to the company. Over longer periods the shares trade with IT services peers such as Grid Dynamics, where the shared question is whether AI tools shrink billable engineering work. A broad sell-off in AI software would weigh on EPAM regardless of its buyback, because the growth half of the case rests on the same AI spending.